Advertisement

Topics

Society of Urologic Oncology Release: Novel Gene Therapy Shows Three-Fold Improvement In Recurrence-Free Survival In High-Risk, Early-Stage Bladder Cancer Patients Where Current Gold-Standard Treatment Fails

20:00 EDT 23 Aug 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: Society of Urologic Oncology Release: Novel Gene Therapy Shows Three-Fold Improvement In Recurrence-Free Survival In High-Risk, Early-Stage Bladder Cancer Patients Where Current Gold-Standard Treatment Fails

NEXT ARTICLE

More From BioPortfolio on "Society of Urologic Oncology Release: Novel Gene Therapy Shows Three-Fold Improvement In Recurrence-Free Survival In High-Risk, Early-Stage Bladder Cancer Patients Where Current Gold-Standard Treatment Fails"

Advertisement
Quick Search
Advertisement
Advertisement